Skip To Main Content
Ying-Rui Shi on Muck Rack

Ying-Rui Shi

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ying-Rui

Contact Ying-Rui, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

|
By Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, Chaosu Hu, Kunyu Yang, Jiyu Wen, Jingao Li, Feng Jin, Ruilian Xu, Jianji Pan, Shenhong Qu, Ping Li, Chunhong Hu, Yi-Chun Carol Liu, Yi Jiang, Xia He, Hung-Ming Wang, Wan-Teck Lim, Wangjun Liao, Xiaohui He, Xiaozhong Chen, Zhigang Liu, Xianglin Yuan, Qi Li, Xiaoyan Lin, Shanghua Jing, Yanju Chen, Yin Lu, Ching-Yun Hsieh, Muh-Hwa Yang, Chia-Jui Yen, Jens Samol, Hui Feng, Sheng Yao, Patricia Keegan, Rui-hua Xu, Ying-Rui Shi
| Nature Verified
Correction to: Nature Medicine https://doi.org/10.1038/s41591-021-01444-0, published online 2 August 2021. In the version of this article initially published, in the Results section, there was an error in the number and percentage of patients who continued maintenance treatment after chemotherapy, which should have read 233 (80.6%) rather than 231 (79.9%). The corresponding total in the legend to Extended Data Fig. 1 should have read 233 rather than 231. In Fig.
Open in Who Shared Issue with article?
See all 1 articles